This inventor holds 2 USPTO granted patents and 18 published patent applications and 2 EPO patents. Top assignee: Genentech, Inc.. Active years: 2009-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2017
Title: Gwendolyn Fyfe: Innovator in Cancer Treatment
Introduction
Gwendolyn Fyfe is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of medical treatment, particularly in the area of cancer therapy. With a total of 2 patents, her work focuses on innovative approaches to combat diseases using advanced therapeutic agents.
Latest Patents
Gwendolyn Fyfe's latest patents revolve around the treatment of diseases and pathological conditions with anti-VEGF antibodies. Specifically, her inventions address the treatment of human patients who are susceptible to or diagnosed with cancer. The use of anti-VEGF antibodies, preferably in combination with additional anti-tumor therapeutic agents, represents a significant advancement in cancer treatment methodologies.
Career Highlights
Throughout her career, Gwendolyn has worked with notable companies such as Genentech, Inc. and F. Hoffmann-La Roche AG. Her experience in these leading organizations has allowed her to develop and refine her innovative ideas in the medical field.
Collaborations
Gwendolyn has collaborated with esteemed colleagues, including Eric Holmgren and William F. Novotny. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Gwendolyn Fyfe's contributions to cancer treatment through her innovative patents and collaborations highlight her role as a leading inventor in the medical field. Her work continues to pave the way for new therapeutic strategies that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile